Does Texas Medicaid Cover Wegovy or Zepbound?
Texas (TX) GLP-1 access depends on three state-specific policy questions before it ever gets to pricing: does Texas Medicaid cover weight-loss GLP-1s, has Texas expanded Medicaid under the ACA, and does the state employee health plan cover them. Answering those first tells you whether you're likely working with insurance or planning for cash-pay.
Texas Medicaid GLP-1 coverage: what the state's own documents say
Texas Medicaid has no coverage pathway for weight management alone: its prior authorization criteria approve Wegovy only for cardiovascular risk reduction or MASH, Zepbound only for moderate-to-severe obstructive sleep apnea, and GLP-1 receptor agonists otherwise only with a type 2 diabetes diagnosis. A separate prior authorization covers older appetite-suppressant drugs (phentermine and similar).
Checked September 20, 2026 against: paxpress-txpa.acentra.com, paxpress-txpa.acentra.com, paxpress-txpa.acentra.com, hhs.texas.gov.
Texas state employee health plan: what the plan's own documents say
The Texas HealthSelect medical plan excludes services and supplies for reduction of obesity or weight, including prescription drugs, in both the plan year 2026 and plan year 2027 plan documents, and ERS's Express Scripts drug list marks Saxenda, Wegovy and Zepbound as not covered. Only the Wondr and Real Appeal weight programs and bariatric surgery meeting criteria are covered.
Checked September 20, 2026 against: healthselect.bcbstx.com, healthselect.bcbstx.com, express-scripts.com.
Notable insurers active in Texas (not independently verified): Blue Cross Blue Shield of Texas, UnitedHealthcare, Cigna.
Why GLP-1 coverage varies this much by state
Medicaid is a state-federal partnership, not a single national program. Each state Medicaid agency sets its own preferred drug list (PDL) and prior-authorization criteria within federal minimum requirements. Weight-loss drugs are not a federally mandated Medicaid benefit, so states choose independently whether to cover them - which is why only 10 of 50 states currently do (Texas is not one of them).
State employee health plans are a useful bellwether. These plans cover hundreds of thousands of state workers and negotiate directly with pharmacy benefit managers, so their coverage decisions often signal where commercial insurers in that state are heading. North Carolina's State Health Plan, for example, ended coverage of weight-loss GLP-1s on April 1, 2024, after its board voted 4-3 to cut it citing the drugs' high cost - a case that other states and large employers have watched closely.
Medicaid expansion status shapes who even has coverage to begin with. States that haven't adopted ACA Medicaid expansion have narrower Medicaid eligibility overall, which - combined with the weight-loss GLP-1 exclusion most states apply regardless of expansion status - pushes a larger share of residents in those states toward commercial insurance, telehealth, or manufacturer self-pay as their only realistic path.
National reference pricing (same nationwide - your actual cost depends on your plan)
These prices are the same across all 50 states because manufacturer list prices, self-pay programs, and telehealth pricing don't vary by state - only insurance coverage and copay do, which is why the Texas-specific policy facts above matter more than the table below for predicting your actual cost.
| Drug | Covered by insurance | Manufacturer self-pay | Telehealth | Cash retail |
|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $1,349 |
| Ozempic 11.6% weight loss | $63 | - | $399 | $1,028 |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 | $449 | $1,349 |
| Zepbound 22.5% weight loss | $88 | $299 | $499 | $1,059 |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $1,069 |
| Saxenda 8.4% weight loss | $63 | - | $399 | $1,349 |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 | - | $1,099 |
| CagriSema 20.4% weight loss | $88 | $599 | - | $1,499 |
Cheapest cash-pay GLP-1 paths for Texas residents
Manufacturer direct prices (LillyDirect, NovoCare) are usually cheapest. Updated May 2026.
| Drug | Insurance | Mfr direct | Telehealth (brand) | Telehealth (compd) | Cash retail | Get it |
|---|---|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $249 cheapest | $1,349 | Get →ad |
| Ozempic 11.6% weight loss | $63 | - | $399 | $199 cheapest | $1,028 | Get →ad |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 cheapest | $449 | - | $1,349 | Get →ad |
| Zepbound 22.5% weight loss | $88 | $299 cheapest | $499 | $299 cheapest | $1,059 | Get →ad |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $299 cheapest | $1,069 | Get →ad |
| Saxenda 8.4% weight loss | $63 | - | $399 cheapest | - | $1,349 | Get →ad |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 cheapest | - | - | $1,099 | Get →ad |
Texas carrier coverage details
National carriers active in Texas (this list is not independently verified). Drill into each carrier's prior-auth requirements, formulary, and appeal playbook.
Frequently asked questions
Does Texas Medicaid cover Wegovy or Zepbound for weight loss?
No. Texas Medicaid has no coverage pathway for weight management alone: its prior authorization criteria approve Wegovy only for cardiovascular risk reduction or MASH, Zepbound only for moderate-to-severe obstructive sleep apnea, and GLP-1 receptor agonists otherwise only with a type 2 diabetes diagnosis. A separate prior authorization covers older appetite-suppressant drugs (phentermine and similar). This was checked against Texas's own documents on September 20, 2026; coverage rules change often, so confirm with your plan before relying on it. Coverage for type 2 diabetes (Ozempic, Mounjaro) is a separate question. Medicare's GLP-1 Bridge, which started July 1, 2026, works separately from Medicaid and applies in every state.
Has Texas expanded Medicaid under the ACA?
No - Texas has not adopted ACA Medicaid expansion, which narrows Medicaid eligibility generally and, combined with GLP-1 weight-loss exclusion, pushes more residents toward commercial insurance, telehealth, or manufacturer self-pay programs for GLP-1 access.
Does the Texas state employee health plan cover Wegovy or Zepbound?
No. The Texas HealthSelect medical plan excludes services and supplies for reduction of obesity or weight, including prescription drugs, in both the plan year 2026 and plan year 2027 plan documents, and ERS's Express Scripts drug list marks Saxenda, Wegovy and Zepbound as not covered. Only the Wondr and Real Appeal weight programs and bariatric surgery meeting criteria are covered. This was checked against Texas's own plan documents on September 20, 2026; plan terms are reset each plan year, so confirm with your plan before relying on it.